Global Outsourced Drug Discovery Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Outsourced Drug Discovery Market Insights, Forecast to 2034
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
Market Analysis and InsightsGlobal Outsourced Drug Discovery Market
Global Outsourced Drug Discovery market is expected to reach to US$ 18200 million in 2023, with a positive growth of %, compared with US$ 17840 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Outsourced Drug Discovery industry is evaluated to reach US$ 34250 million in 2033. The CAGR will be 11.1% during 2023 to 2033.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Covers
This report presents an overview of global Outsourced Drug Discovery market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Outsourced Drug Discovery market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Outsourced Drug Discovery introduction, etc. Outsourced Drug Discovery Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Outsourced Drug Discovery
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Outsourced Drug Discovery Market
Global Outsourced Drug Discovery market is expected to reach to US$ 18200 million in 2023, with a positive growth of %, compared with US$ 17840 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Outsourced Drug Discovery industry is evaluated to reach US$ 34250 million in 2033. The CAGR will be 11.1% during 2023 to 2033.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Covers
This report presents an overview of global Outsourced Drug Discovery market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Outsourced Drug Discovery market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Segment by Application
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Outsourced Drug Discovery introduction, etc. Outsourced Drug Discovery Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Outsourced Drug Discovery
Chapter 13Methodology and Data Sources adopted by MRAResearch